5'-azacytidine 5'-monophosphate has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gluckman, PD; Lobie, PE; Mitchell, MD; Pawella, L; Rahnama, F; Shafiei, F | 1 |
Bystricky, K; Fleury, L; Gerus, M; Lavigne, AC; Richard-Foy, H | 1 |
2 other study(ies) available for 5'-azacytidine 5'-monophosphate and Breast Neoplasms
Article | Year |
---|---|
DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Autocrine Communication; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA, Neoplasm; Female; gamma Catenin; Gene Expression Regulation, Neoplastic; Growth Hormone; Humans; Neoplasm Proteins; Phenotype; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering | 2008 |
Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; CpG Islands; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Receptors, Progesterone; RNA, Small Interfering | 2008 |